# Cardiopulmonary Bypass Equipment Devices Market > Cardiopulmonary Bypass Equipment Devices Market Research Report Information by Product Type (Single Roller Pump and Double Roller Pump), by End User (Hospitals and Ambulatory Surgical Centres) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 2.2% - **2024:** $ 0.16 Billion - **2025:** $ 0.16 Billion - **2035:** $ 0.2 Billion - **Key Players:** Medtronic (US), Terumo Corporation (JP), Cardinal Health (US), Getinge AB (SE), LivaNova PLC (GB), Abbott Laboratories (US), Sorin Group (IT), B. Braun Melsungen AG (DE) **Report ID:** MRFR/HC/14693-HCR · **Pages:** 128 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/cardiopulmonary-bypass-equipment-devices-market-16221 --- ## Market Summary ## **Cardiopulmonary Bypass Equipment Devices Market Overview** As per MRFR analysis, the Cardiopulmonary Bypass Equipment Devices Market Size was estimated at 0.16 (USD Billion) in 2024. The Cardiopulmonary Bypass Equipment Devices Market Industry is expected to grow from 0.16 (USD Billion) in 2025 to 0.20 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 2.20% during the forecast period (2025 - 2034). Increased prevalence of cardiovascular diseases and rising demand for cardiac surgeries are the key market drivers fueling the market growth. ## **Cardiopulmonary Bypass Equipment Devices****Market Trends** Market CAGR for cardiopulmonary bypass equipment devices is being driven by the escalating prevalence of cardiovascular diseases (CVDs) globally. Cardiovascular diseases, including coronary artery disease, valvular heart disease, and congenital heart defects, continue to be a leading cause of morbidity and mortality. As the incidence of these conditions rises due to factors such as aging populations, sedentary lifestyles, and dietary changes, the demand for cardiac interventions and surgeries also increases. Cardiopulmonary bypass (CPB) plays a crucial role in cardiac surgeries by temporarily taking over the function of the heart and lungs, allowing surgeons to perform intricate procedures. With the growing burden of cardiovascular diseases, there is a parallel increase in the number of cardiac surgeries, creating a sustained demand for Cardiopulmonary Bypass Equipment Devices. Hospitals and healthcare facilities, recognizing the need to address the rising cases of heart-related conditions, are investing in advanced CPB technologies to enhance patient outcomes and improve the overall efficacy of cardiac procedures. Advancements in perfusion technologies represent a significant driver propelling the Cardiopulmonary Bypass Equipment Devices market forward. Perfusion refers to the process of supplying oxygen and nutrients to the body's tissues and organs while removing waste products. In the context of [cardiac surgeries](../../../reports/cardiac-surgery-instruments-market-2856), perfusion technology is employed to maintain adequate blood circulation and oxygenation during the period when the heart is temporarily stopped for the surgical procedure. Additionally, rising awareness among healthcare professionals and patients about the benefits of cardiopulmonary bypass in complex cardiac surgeries is another key driver of market growth. As medical knowledge and education continue to advance. There is a greater demand for the role of CPB in enabling intricate and life-saving cardiac procedures. The temporary suspension of heart and lung function provided by CPB allows surgeons the necessary time and conditions to perform surgeries with precision. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths annually. The American Heart Association reports that nearly half of all adults in the United States have some form of cardiovascular disease. As a result, it is anticipated that throughout the projection period, demand for Cardiopulmonary Bypass Equipment Devices will increase due to the rising preference for Cardiopulmonary Bypass Equipment Devices. Thus, driving the Cardiopulmonary Bypass Equipment Devices market revenue. ## **Cardiopulmonary Bypass Equipment Devices Market Segment Insights** ### **Cardiopulmonary Bypass Equipment Devices Product Type Insights** The Cardiopulmonary Bypass Equipment Devices Market segmentation, based on product type includes Single Roller Pump and Double Roller Pump. The double roller pump segment dominated the market, accounting for more than half of market revenue. This is attributed to its advantages over single roller pumps in terms of stability, precision, and reduced pulsatility in blood flow during cardiopulmonary bypass procedures. ### **Cardiopulmonary Bypass Equipment Devices End User Insights** The Cardiopulmonary Bypass Equipment Devices Market segmentation, based on End User includes Hospitals and Ambulatory Surgical Centres. The hospitals segment dominated the market, accounting for above half of market revenue. Hospitals serve as the primary hubs for complex cardiac surgeries and interventions that require cardiopulmonary bypass. **Figure 1: Cardiopulmonary Bypass Equipment Devices Market, by End User, 2022 & 2032 (USD Billion)** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ### **Cardiopulmonary Bypass Equipment Devices Regional Insights** By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. The North American Cardiopulmonary Bypass Equipment Devices market area will dominate this market. North America region has advanced healthcare infrastructure and a high level of awareness regarding cardiovascular diseases. The prevalence of cardiac conditions, coupled with a well-established healthcare system, leads to a significant demand for cardiac surgeries and related technologies. Further, the major countries studied in the market report are The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. **Figure 2: CARDIOPULMONARY BYPASS EQUIPMENT DEVICES MARKET SHARE BY REGION 2022 (USD Billion)** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review Europe Cardiopulmonary Bypass Equipment Devices market accounts for the second-largest market share owing to its well-developed healthcare infrastructure, a large patient population with cardiovascular diseases, and a strong emphasis on technological advancements in medical care. Further, the German Cardiopulmonary Bypass Equipment Devices market held the largest market share, and the UK Cardiopulmonary Bypass Equipment Devices market was the fastest-growing market in the European region The Asia-Pacific Cardiopulmonary Bypass Equipment Devices Market is expected to grow at the fastest CAGR from 2023 to 2032. The region's large and aging population is experiencing a rise in the prevalence of cardiovascular diseases, creating a growing demand for cardiac interventions. Improved economic conditions in several Asia-Pacific countries have increased healthcare spending, allowing for greater access to advanced medical treatments, including cardiac surgeries. Moreover, China’s Cardiopulmonary Bypass Equipment Devices market held the largest market share, and the Indian Cardiopulmonary Bypass Equipment Devices market was the fastest growing market in the Asia-Pacific region. ### **Cardiopulmonary Bypass Equipment Devices Key Market Players & Competitive Insights** Leading market players are investing heavily in research and development to introduce innovative and technologically advanced Cardiopulmonary Bypass Equipment Devices. Market participants are also adopting a variety of strategic activities to expand their worlwide footprint, with important market developments including new product launches, contractual agreements, Customer Education and Training, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Cardiopulmonary Bypass Equipment Devices industry must offer innovative solution. Offering customization options and tailored solutions to meet the specific needs of different healthcare facilities is one of the key business tactics used by manufacturers in the global Cardiopulmonary Bypass Equipment Devices industry to increase the market share. In recent years, the Cardiopulmonary Bypass Equipment Devices industry has offered some of the most significant advantages to Consumers. Major players in the Cardiopulmonary Bypass Equipment Devices market, including Medtronic Plc, LivaNova PLC, Braile Biomedica, Tianjin Medical, MAQUET Holding B.V. & Co. KG., Terumo Corporation, and others, are attempting to increase market demand by offering Post-Sale Support and Service to contributes to customer satisfaction. Medtronic is a big healthcare technology company that's making a difference in global health. They have a huge team of over 95,000 people in more than 150 countries. Medtronic is focused on making healthcare technology more available, supporting inclusion, diversity, and fairness, and caring about the environment. Their mission, based on biomedical engineering, is all about creating, making, and sharing tools that help with pain, bring back health, and make life longer. Medtronic is really committed to helping people, and they work hard to find new solutions that make a positive impact on lives and improve healthcare worldwide. In November 2023, Medtronic plc introduced its Penditure Left Atrial Appendage (LAA) Exclusion System in the United States. This system includes an inventive, implantable clip that is pre-loaded on a single-use delivery tool. It is designed for managing the left atrial appendage (LAAM) during concurrent cardiac surgery procedures. LivaNova, PLC, is a company that makes special medical devices for heart surgery and neuromodulation. It started in 2015 when two companies, Cyberonics, Inc. from Texas and Sorin S.p.a. from Italy, joined together in a big merger worth $2.7 billion. LivaNova quickly became a big player in the global healthcare industry. You can find its stock trading on the NASDAQ stock exchange under the symbol "LIVN." LivaNova is all about using the latest medical technologies to improve patient care in heart surgery and neuromodulation. This merger made LivaNova a strong force in the market, combining the skills and knowledge of two experienced companies to create new and better ways to help people. In April 2022, LivaNova obtained FDA 510(k) clearance for its B-Capta system, which was integrated into the S5 heart-lung machine. **Key Companies in the Cardiopulmonary Bypass Equipment Devices Market Include** **Cardiopulmonary Bypass Equipment Devices Industry Developments** **April 2022:** LivaNova started the targeted commercial launch of Essenz™, a Patient Monitor designed for cardiopulmonary bypass procedures. The innovative monitoring system adopts a patient-tailored approach to enhance clinical efficiency and the quality of patient care during cardiopulmonary bypass (CPB) procedures. **February 2022:** Getinge obtained 100% of the equity interest in Talis Clinical LLC, a leading innovator of High Acuity cloud-based software solutions based in the US. Talis Clinical's offerings were designed to support and document care across various healthcare processes, including general and cardiac perioperative care, labor and delivery episodes, and critical care support, including ECMO Therapy. ## **Cardiopulmonary Bypass Equipment Devices Market Segmentation** ### **Cardiopulmonary Bypass Equipment Devices Product Type Outlook** ### **Cardiopulmonary Bypass Equipment Devices End User Outlook** ### **Cardiopulmonary Bypass Equipment Devices Regional Outlook** ## Market Drivers ### Growing Geriatric Population The increasing geriatric population is a notable driver for the Cardiopulmonary Bypass Equipment Devices Market. As individuals age, the risk of developing cardiovascular diseases escalates, leading to a higher demand for surgical interventions. The World Health Organization projects that the number of people aged 60 years and older will reach 2 billion by 2050, creating a substantial market for cardiopulmonary bypass devices. This demographic shift necessitates the development of specialized equipment tailored to the needs of older patients, thereby driving innovation and growth within the industry. ### Rising Healthcare Expenditure Rising healthcare expenditure is a critical factor influencing the Cardiopulmonary Bypass Equipment Devices Market. As countries allocate more resources to healthcare, there is an increased investment in advanced medical technologies, including cardiopulmonary bypass equipment. This trend is particularly evident in emerging economies, where healthcare infrastructure is rapidly evolving. Enhanced funding allows for the procurement of state-of-the-art devices, which can improve surgical outcomes and patient care. Consequently, the market is expected to benefit from this upward trajectory in healthcare spending, fostering further advancements in cardiopulmonary bypass technology. ### Regulatory Compliance and Safety Standards The Cardiopulmonary Bypass Equipment Devices Market is significantly influenced by stringent regulatory compliance and safety standards. Regulatory bodies are continuously updating guidelines to ensure the safety and efficacy of medical devices. Manufacturers are compelled to invest in research and development to meet these evolving standards, which can be both a challenge and an opportunity. Compliance with regulations not only enhances product credibility but also fosters consumer trust. As a result, companies that prioritize adherence to safety standards are likely to gain a competitive edge in the market, potentially leading to increased market share. ### Increasing Prevalence of Cardiovascular Diseases The rising incidence of cardiovascular diseases is a primary driver for the Cardiopulmonary Bypass Equipment Devices Market. With an estimated 17.9 million deaths attributed to cardiovascular conditions annually, the need for effective surgical interventions is paramount. This growing patient population necessitates the use of advanced cardiopulmonary bypass devices during surgeries, thereby propelling market growth. Furthermore, as awareness of cardiovascular health increases, more individuals are seeking medical attention, leading to a higher volume of surgical procedures. This trend is likely to continue, further solidifying the demand for innovative bypass equipment. ### Technological Innovations in Cardiopulmonary Bypass Equipment The Cardiopulmonary Bypass Equipment Devices Market is experiencing a surge in technological innovations that enhance the efficiency and safety of surgical procedures. Advanced devices, such as automated [perfusion systems](https://www.marketresearchfuture.com/reports/perfusion-system-market-43691) and improved [oxygenators](https://www.marketresearchfuture.com/reports/oxygenators-market-43746), are being developed to minimize complications during cardiac surgeries. These innovations not only improve patient outcomes but also streamline surgical workflows. The integration of artificial intelligence and machine learning into these devices is expected to further optimize performance. As a result, the market is projected to grow at a compound annual growth rate of approximately 6.5% over the next few years, driven by the demand for more sophisticated and reliable equipment. ## Future Outlook The Cardiopulmonary Bypass Equipment Devices Market is projected to grow at a 2.2% CAGR from 2025 to 2035, driven by technological advancements and increasing surgical procedures. **New opportunities:** - Development of portable cardiopulmonary bypass systems for outpatient surgeries. Integration of AI for predictive maintenance in bypass equipment. Expansion into emerging markets with tailored financing solutions. By 2035, the market is expected to demonstrate steady growth and enhanced technological integration. ## Segment Insights ### By Product Type: Single Roller Pump (Largest) vs. Double Roller Pump (Fastest-Growing) The Cardiopulmonary Bypass Equipment Devices Market showcases a notable distribution of market share between Single Roller Pumps and Double Roller Pumps. The Single Roller Pump holds a substantial position as the largest segment owing to its established usage in clinical settings. On the other hand, the Double Roller Pump is gaining traction, appealing to healthcare providers looking for enhanced performance and efficiency in surgical applications. This fluctuation in market shares highlights the evolving preferences of medical institutions towards advanced technologies in cardiopulmonary procedures. Product Type: Single Roller Pump (Dominant) vs. Double Roller Pump (Emerging) Single Roller Pumps are recognized for their reliability and consistency in cardiopulmonary bypass operations, making them the dominant choice among medical professionals. These pumps provide smooth and steady blood flow, ensuring patient safety during surgeries. Conversely, the Double Roller Pump is emerging as a popular alternative due to its ability to handle higher workloads and its innovative design, which offers flexibility in fluid management. As healthcare facilities continue to invest in cutting-edge technology, the Double Roller Pump is expected to witness rapid growth, driven by the demand for more sophisticated and efficient equipment in cardiovascular surgeries. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centres (Fastest-Growing) In the Cardiopulmonary Bypass Equipment Devices Market, hospitals represent the dominant end users, significantly contributing to the overall market share. This segment is characterized by extensive infrastructure and a high volume of cardiothoracic surgeries performed, making hospitals the primary purchasers of these devices. Ambulatory surgical centers, while smaller in market share compared to hospitals, are experiencing rapid growth as they accommodate an increasing number of outpatient procedures, allowing for more efficient use of resources and lower operational costs. The growth trends for these end-user segments reflect key shifts in healthcare delivery. Hospitals continue to modernize their equipment and improve care quality, thereby maintaining their share of the market. In contrast, the fastest-growing segment, ambulatory surgical centers, is propelled by the trend toward minimally invasive surgeries, patient preference for outpatient care, and advancements in technology that make these procedures safer and more efficient. This evolution indicates a shifting landscape in cardiopulmonary care that emphasizes accessibility and cost-effectiveness in treatment options. Hospitals (Dominant) vs. Ambulatory Surgical Centres (Emerging) Hospitals remain the dominant players in the Cardiopulmonary Bypass Equipment Devices Market, characterized by their robust infrastructure, diverse patient demographics, and a high volume of complex surgeries requiring advanced equipment. They engage in a broad range of procedures, necessitating state-of-the-art cardiopulmonary bypass devices that ensure optimal outcomes. Conversely, ambulatory surgical centers are emerging as key players in this market, driven by a significant shift toward outpatient care. They facilitate simpler, less invasive procedures and are well-positioned to capitalize on healthcare's trend toward operational efficiency. As they adopt advanced technologies and expand their service offerings, these centers are not just gaining ground but are reshaping patient care pathways through increased accessibility and reduced recovery times. ## Regional Market Share Analysis ### North America : Leading Innovation and Demand North America is the largest market for cardiopulmonary bypass equipment, holding approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and significant investments in medical technology. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new devices, enhancing patient outcomes and safety. The United States is the primary contributor, with key players such as Medtronic, Abbott Laboratories, and [Cardinal Health](https://www.marketresearchfuture.com/reports/cardinal-health-market-66150) leading the market. The competitive landscape is characterized by continuous product development and strategic partnerships. Canada also plays a significant role, focusing on improving healthcare access and technology integration, thereby supporting market growth in the region. ### Europe : Regulatory Support and Growth Europe is the second-largest market for cardiopulmonary bypass equipment, accounting for around 30% of the global market share. The region benefits from stringent regulatory frameworks that ensure high-quality standards and patient safety. Increasing investments in healthcare infrastructure and rising awareness about cardiovascular diseases are key growth drivers. The European Union's initiatives to enhance healthcare access and innovation further support market expansion. Leading countries include Germany, the UK, and France, where major players like Getinge AB and B. Braun Melsungen AG are prominent. The competitive landscape is marked by collaborations and technological advancements, with a focus on minimally invasive procedures. The presence of robust healthcare systems and research institutions fosters innovation, making Europe a vital hub for cardiopulmonary device development. ### Asia-Pacific : Rapid Growth and Adoption Asia-Pacific is witnessing rapid growth in the cardiopulmonary bypass equipment market, holding approximately 20% of the global share. The region's expansion is fueled by increasing healthcare expenditure, rising prevalence of heart diseases, and a growing aging population. Countries like China and India are investing heavily in healthcare infrastructure, which is expected to drive demand for advanced medical devices in the coming years. China is the largest market in the region, with significant contributions from local manufacturers and international players like Terumo Corporation. The competitive landscape is evolving, with a focus on affordability and accessibility of healthcare solutions. Additionally, government initiatives aimed at improving healthcare services are expected to further boost market growth in Asia-Pacific, making it a key area for future investments. ### Middle East and Africa : Emerging Markets and Opportunities The Middle East and Africa region is gradually emerging in the cardiopulmonary bypass equipment market, holding about 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of cardiovascular diseases, and government initiatives to improve healthcare infrastructure. Countries like the UAE and South Africa are leading the way, with a focus on enhancing medical services and technology adoption. The competitive landscape is characterized by a mix of local and international players, with companies like LivaNova PLC and Sorin Group making significant inroads. The region's unique challenges, such as varying healthcare access and economic disparities, present both challenges and opportunities for market players. As healthcare systems evolve, the demand for advanced cardiopulmonary devices is expected to rise, paving the way for future growth. ## Competitive Benchmarking The Cardiopulmonary Bypass Equipment Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for minimally invasive surgical procedures. Key players such as Medtronic (US), Terumo Corporation (JP), and Getinge AB (SE) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) focuses on innovation through the development of advanced perfusion technologies, while Terumo Corporation (JP) emphasizes regional expansion, particularly in emerging markets. Getinge AB (SE) is actively pursuing partnerships to bolster its product offerings, thereby shaping a competitive environment that is increasingly collaborative and innovation-driven.The market structure appears moderately fragmented, with several players vying for market share. Companies are employing various business tactics, such as localizing manufacturing to reduce costs and optimize supply chains. This approach not only enhances operational efficiency but also allows for quicker responses to regional market demands. The collective influence of these key players fosters a competitive atmosphere where agility and adaptability are paramount, as they navigate the complexities of global supply chains and regulatory environments. In August Medtronic (US) announced the launch of its next-generation cardiopulmonary bypass system, which integrates advanced monitoring capabilities and AI-driven analytics. This strategic move is likely to enhance patient outcomes by providing real-time data to clinicians, thereby improving decision-making during surgeries. The introduction of such innovative technologies positions Medtronic (US) as a leader in the market, potentially setting new standards for performance and reliability in cardiopulmonary bypass procedures. In July Terumo Corporation (JP) expanded its manufacturing capabilities in Southeast Asia, aiming to meet the growing demand for cardiopulmonary bypass devices in the region. This expansion not only signifies Terumo's commitment to localizing production but also reflects a strategic response to the increasing surgical volume in emerging markets. By enhancing its operational footprint, Terumo Corporation (JP) is likely to strengthen its competitive edge and improve supply chain resilience. In September Getinge AB (SE) entered into a strategic partnership with a leading digital health company to develop integrated solutions for cardiac surgery. This collaboration is indicative of a broader trend towards digitalization within the healthcare sector, where the integration of technology is becoming essential for improving surgical outcomes. By aligning with digital health innovations, Getinge AB (SE) is positioning itself to leverage data analytics and telemedicine, which could redefine patient care in cardiopulmonary procedures. As of October the competitive trends in the Cardiopulmonary Bypass Equipment Devices Market are increasingly influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing product offerings. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and the ability to deliver superior patient outcomes. This shift underscores the importance of innovation as a key driver of success in the market. ## Recent News & Developments **April 2022:** LivaNova started the targeted commercial launch of Essenz™, a Patient Monitor designed for cardiopulmonary bypass procedures. The innovative monitoring system adopts a patient-tailored approach to enhance clinical efficiency and the quality of patient care during cardiopulmonary bypass (CPB) procedures. **February 2022:** Getinge obtained 100% of the equity interest in Talis Clinical LLC, a leading innovator of High Acuity cloud-based software solutions based in the US. Talis Clinical's offerings were designed to support and document care across various healthcare processes, including general and cardiac perioperative care, labor and delivery episodes, and critical care support, including ECMO Therapy. ## Report Scope | MARKET SIZE 2024 | 0.1584(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 0.1619(USD Billion) | | MARKET SIZE 2035 | 0.2013(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.2% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Medtronic (US), Terumo Corporation (JP), Cardinal Health (US), Getinge AB (SE), LivaNova PLC (GB), Abbott Laboratories (US), Sorin Group (IT), B. Braun Melsungen AG (DE) | | Segments Covered | Product Type, End User, Region | | Key Market Opportunities | Integration of advanced monitoring technologies enhances patient safety in the Cardiopulmonary Bypass Equipment Devices Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the cardiopulmonary bypass equipment devices market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation for the Cardiopulmonary Bypass Equipment Devices Market in 2035?** A: The projected market valuation for the Cardiopulmonary Bypass Equipment Devices Market in 2035 is 0.2013 USD Billion. **Q: What was the market valuation for the Cardiopulmonary Bypass Equipment Devices Market in 2024?** A: The market valuation for the Cardiopulmonary Bypass Equipment Devices Market in 2024 was 0.1584 USD Billion. **Q: What is the expected CAGR for the Cardiopulmonary Bypass Equipment Devices Market from 2025 to 2035?** A: The expected CAGR for the Cardiopulmonary Bypass Equipment Devices Market during the forecast period 2025 - 2035 is 2.2%. **Q: Which companies are considered key players in the Cardiopulmonary Bypass Equipment Devices Market?** A: Key players in the Cardiopulmonary Bypass Equipment Devices Market include Medtronic, Terumo Corporation, Cardinal Health, Getinge AB, LivaNova PLC, Abbott Laboratories, Sorin Group, and B. Braun Melsungen AG. **Q: What are the product types included in the Cardiopulmonary Bypass Equipment Devices Market?** A: The product types in the Cardiopulmonary Bypass Equipment Devices Market include Single Roller Pumps and Double Roller Pumps. **Q: What was the market size for Single Roller Pumps in 2024?** A: The market size for Single Roller Pumps in 2024 was 0.0792 USD Billion. **Q: What is the projected market size for Double Roller Pumps in 2035?** A: The projected market size for Double Roller Pumps in 2035 is expected to be approximately 0.1006 USD Billion. **Q: Which end users are primarily involved in the Cardiopulmonary Bypass Equipment Devices Market?** A: The primary end users in the Cardiopulmonary Bypass Equipment Devices Market are hospitals and ambulatory surgical centres. **Q: What was the market valuation for hospitals in the Cardiopulmonary Bypass Equipment Devices Market in 2024?** A: The market valuation for hospitals in the Cardiopulmonary Bypass Equipment Devices Market in 2024 was 0.09504 USD Billion. **Q: What is the projected market size for ambulatory surgical centres in 2035?** A: The projected market size for ambulatory surgical centres in 2035 is expected to be around 0.07826 USD Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/cardiopulmonary-bypass-equipment-devices-market-16221*